306 related articles for article (PubMed ID: 24114734)
1. Efficacy of dimetinden and hydroxyzine/chlorpheniramine in atopic dogs: a randomised, controlled, double-blinded trial.
Eichenseer M; Johansen C; Mueller RS
Vet Rec; 2013 Nov; 173(17):423. PubMed ID: 24114734
[TBL] [Abstract][Full Text] [Related]
2. Additive benefits of EFAs in dogs with atopic dermatitis after partial response to antihistamine therapy.
Paterson S
J Small Anim Pract; 1995 Sep; 36(9):389-94. PubMed ID: 8583767
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cyclosporine-sparing effects of polyunsaturated fatty acids in the treatment of canine atopic dermatitis.
Müller MR; Linek M; Löwenstein C; Röthig A; Doucette K; Thorstensen K; Mueller RS
Vet J; 2016 Apr; 210():77-81. PubMed ID: 26975448
[TBL] [Abstract][Full Text] [Related]
4. Antihistamines in the management of canine atopic dermatitis: a retrospective study of 171 dogs (1992-1998).
Zur G; Ihrke PJ; White SD; Kass PH
Vet Ther; 2002; 3(1):88-96. PubMed ID: 12050832
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
6. A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.
Michels GM; Ramsey DS; Walsh KF; Martinon OM; Mahabir SP; Hoevers JD; Walters RR; Dunham SA
Vet Dermatol; 2016 Dec; 27(6):478-e129. PubMed ID: 27647569
[TBL] [Abstract][Full Text] [Related]
7. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
[TBL] [Abstract][Full Text] [Related]
8. Use of antipruritic and rehydrating foams on localized lesions of atopic dermatitis in dogs: a small-scale pilot and comparative double-blinded study.
Bensignor EJ; Fabriès LJ
Vet Dermatol; 2018 Oct; 29(5):446-e150. PubMed ID: 30079617
[TBL] [Abstract][Full Text] [Related]
9. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Horvath-Ungerboeck C; Thoday KL; Shaw DJ; van den Broek AH
Vet Dermatol; 2009 Aug; 20(4):233-42. PubMed ID: 19552701
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D
Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302
[TBL] [Abstract][Full Text] [Related]
11. Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.
Dip R; Carmichael J; Letellier I; Strehlau G; Roberts E; Bensignor E; Rosenkrantz W
BMC Vet Res; 2013 Sep; 9():173. PubMed ID: 24004561
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis.
Marsella R; Cornegliani L; Ozmen I; Bohannon M; Ahrens K; Santoro D
Vet Dermatol; 2017 Dec; 28(6):577-e140. PubMed ID: 28736984
[TBL] [Abstract][Full Text] [Related]
13. Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial.
Ahlstrom LA; Mason KV; Mills PC
J Vet Pharmacol Ther; 2010 Dec; 33(6):573-82. PubMed ID: 21062310
[TBL] [Abstract][Full Text] [Related]
14. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
Cosgrove SB; Wren JA; Cleaver DM; Walsh KF; Follis SI; King VI; Tena JK; Stegemann MR
Vet Dermatol; 2013 Dec; 24(6):587-97, e141-2. PubMed ID: 24581322
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
16. Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.
Tamamoto-Mochizuki C; Murphy KM; Olivry T
Vet Dermatol; 2018 Feb; 29(1):29-e14. PubMed ID: 28952176
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled trial.
Takahashi J; Kanda S; Imanishi I; Hisano T; Fukamachi T; Taguchi N; Momiyama S; Nishiyama S; Motegi T; Iyori K
Vet Dermatol; 2021 Apr; 32(2):119-e25. PubMed ID: 33185330
[TBL] [Abstract][Full Text] [Related]
18. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
[TBL] [Abstract][Full Text] [Related]
19. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
20. Comparison of various treatment options for canine atopic dermatitis: a blinded, randomized, controlled study in a colony of research atopic beagle dogs.
Marsella R; Ahrens K; Wilkes R; Trujillo A; Dorr M
Vet Dermatol; 2020 Aug; 31(4):284-e69. PubMed ID: 32301565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]